This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis (HIT)

This study is currently recruiting participants.
See Contacts and Locations
Verified January 2017 by Institut Curie
Sponsor:
Collaborators:
Hoffmann-La Roche
Centre Leon Berard
Groupe Hospitalier Pitie-Salpetriere
Centre Oscar Lambret
Centre Francois Baclesse
Institut Bergonié
University Hospital, Toulouse
Institut du Cancer de Montpellier - Val d'Aurelle
University Hospital, Grenoble
Information provided by (Responsible Party):
Institut Curie
ClinicalTrials.gov Identifier:
NCT01373710
First received: May 24, 2011
Last updated: January 23, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2019
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)